Form 4 for TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-03 · accession 0000950170-24-025982 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2024-03-05 | 2024-03-03+ | TEVA | Daniell Richard | EVP, European Commercial | M - OptEx | — | +95.8K | 132.0K | +264% | — |
| DMT | 2024-03-05 | 2024-03-04 | TEVA | Daniell Richard | EVP, European Commercial | S - Sale+OE | $13.34 | -95.8K | 69.8K | -58% | -$1.28M |
| DMT | 2024-03-05 | 2024-03-03+ | TEVA | Daniell Richard | EVP, European Commercial | M - OptEx | $0.00 | -95.8K | 67.0K | -59% | $0 |
| DT | 2024-03-05 | 2024-03-04 | TEVA | Daniell Richard | EVP, European Commercial | A - Grant | $0.00 | +81.8K | 81.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-03-04 | M | A | 33,512 | — | 103,282 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. |
| 2 | Common | Ordinary Shares | 2024-03-04 | S | D | 33,512 | $13.34 | 69,770 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.25 to $13.445, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Ordinary Shares | 2024-03-03 | M | A | 62,250 | — | 132,020 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. |
| 4 | Common | Ordinary Shares | 2024-03-04 | S | D | 62,250 | $13.34 | 69,770 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.25 to $13.445, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 5 | Derivative | Restricted Share Units | 2024-03-03 | M | D | 62,250 | $0.00 | 186,753 | D | — · — to — | 62,250 Ordinary Shares | (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F5) Restricted share units were granted on March 3, 2023, with 62,250 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 62,253 vesting on March 3, 2027. |
| 6 | Derivative | Restricted Share Units | 2024-03-04 | A | A | 81,845 | $0.00 | 81,845 | D | — · — to — | 81,845 Ordinary Shares | (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F7) Restricted share units were granted on March 4, 2024, with 20,461 vesting on each of March 4, 2025, March 4, 2026 and March 4, 2027, and 20,462 vesting on March 4, 2028. |
| 7 | Derivative | Restricted Share Units | 2024-03-04 | M | D | 33,512 | $0.00 | 67,024 | D | — · — to — | 33,512 Ordinary Shares | (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F6) Restricted share units were granted on March 4, 2022, with 33,512 vested on March 4, 2023 and March 4, 2024, and 33,512 vesting on each of March 4, 2025 and March 4, 2026. |